Publication

Periostin promotes liver fibrogenesis by activating lysyl oxidase in hepatic stellate cells

Downloadable Content

Persistent URL
Last modified
  • 05/21/2025
Type of Material
Authors
    Pradeep Kumar, Emory UniversityTekla Smith, Emory UniversityReben Raeman, University of PittsburghDaniel M Chopyk, Emory UniversityHannah Brink, Georgia Institute of TechnologyYunshan Liu, Emory UniversityTodd Sulchek, Georgia Institute of TechnologyFrank Anania, Emory University
Language
  • English
Date
  • 2018-08-17
Publisher
  • American Society for Biochemistry and Molecular Biology
Publication Version
Copyright Statement
  • © 2018 by The American Society for Biochemistry and Molecular Biology, Inc.
Final Published Version (URL)
Title of Journal or Parent Work
ISSN
  • 0021-9258
Volume
  • 293
Issue
  • 33
Start Page
  • 12781
End Page
  • 12792
Grant/Funding Information
  • This work was supported by NIDDK, National Institutes of Health, Grants RO1 DK062092, DK111678, and DK113147 (all to F. A. A.).
  • A portion of this work was also supported by funds from Emory University.
Supplemental Material (URL)
Abstract
  • Liver fibrosis arises from dysregulated wound healing due to persistent inflammatory hepatic injury. Periostin is a nonstructural extracellular matrix protein that promotes organ fibrosis in adults. Here, we sought to identify the molecular mechanisms in periostin-mediated hepatic fibrosis. Hepatic fibrosis in periostin/ mice was attenuated as evidenced by significantly reduced collagen fibril density and liver stiffness compared with those in WT controls. A single dose of carbon tetrachloride caused similar acute liver injury in periostin/ and WT littermates, and we did not detect significant differences in transaminases and major fibrosis-related hepatic gene expression between these two genotypes. Activated hepatic stellate cells (HSCs) are the major periostin-producing liver cell type. We found that in primary rat HSCs in vitro, periostin significantly increases the expression levels and activities of lysyl oxidase (LOX) and lysyl oxidase–like (LOXL) isoforms 1–3. Periostin also induced expression of intra- and extracellular collagen type 1 and fibronectin in HSCs. Interestingly, periostin stimulated phosphorylation of SMAD2/3, which was sustained despite short hairpin RNA–mediated knockdown of transforming growth factor (TGF) receptor I and II, indicating that periostin-mediated SMAD2/3 phosphorylation is independent of TGF receptors. Moreover, periostin induced the phosphorylation of focal adhesion kinase (FAK) and AKT in HSCs. Notably, siRNA-mediated FAK knockdown failed to block periostin-induced SMAD2/3 phosphorylation. These results suggest that periostin promotes enhanced matrix stiffness in chronic liver disease by activating LOX and LOXL, independently of TGF receptors. Hence, targeting periostin may be of therapeutic benefit in combating hepatic fibrosis.
Author Notes
Keywords
Research Categories
  • Chemistry, Biochemistry
  • Health Sciences, Pathology

Tools

Relations

In Collection:

Items